13,14-dihydro-15-keto Prostaglandin E2

Mfr.No.	T84586
Description	13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) serves as the predominant metabolite of PGE2 in plasma, created through a 15-keto PGE2 intermediate by the action of 15-oxo-PG delta13 reductase. Unlike its precursor PGE2, this compound exhibits poor binding affinity towards EP2 and EP4 PGE2 receptors (Ki values of 12 and 57 uM, respectively) in CHO cells and fails to stimulate adenylate cyclase activity therein (EC50s >18 and >38 uM, respectively). Concentrations of 13,14-dihydro-15-keto PGE2 are notably higher in the plasma of pregnant women during their third trimester and at labor and delivery stages, whereas its levels are found to be reduced in the tumor tissues of patients with non-small cell lung cancer (NSCLC) compared to adjacent healthy tissue.
Signaling Pathways	Others
Cas Number	363-23-5
Target	Others

Have you used this product?

SKU	Supplier No.	Size	Your price	Quantity
BHB20445855	T84586	10 mg	-		Add to Quote
BHB20445855	T84586	50 mg	-		Add to Quote